FTC Enforcement and the 2024 Interim Report The FTCs interim report on PBM practices, released in July 2024, documented that the six largest PBMs (the Big Three plus Prime Therapeutics, Humana Pharmacy Solutions, and MedImpact) dispensed 79% of all specialty prescriptions through affiliated pharmacies, resulting in higher costs to plan sponsors than independent pharmacy alternatives in numerous documented instances
Everything is naturally flavored with steviano artificial colors, sweeteners, or preservatives
When I walked into Dr
The site author is identified in the article byline
To explore differences in (i) past-year use of GLP-1 or GLP-1/GIP medication to support weight loss and (ii) interest in using a weight-loss medication in the next year between population subgroups, we estimated these proportions stratified by gender, age, ethnicity, occupational social grade, financial situation, health-related economic inactivity, smoking status, alcohol consumption, past-month distress, and history of eating disorders
Comparison of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter protein-2 inhibitors on treating metabolic dysfunction-associated steatotic liver disease or metabolic dysfunction-associated steatohepatitis: systematic review and network meta-analysis of randomised controlled trials
